PAK1 is upregulated in various cancer types, integrates various signalling pathways, such as PI3K and RAS, and has been reported to phosphorylate and inactivate FOXO1 in breast cancer (Mazumdar et al., 2003) and FOXO6 in liver ageing (Kim et al., 2015). This evidence concerns the gene FOXO6 and breast carcinoma.